We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Size of Hemorrhagic Stroke Reduced by Indian Spice

By LabMedica International staff writers
Posted on 16 Oct 2008
Curcumin, an active ingredient of the Indian curry spice, turmeric, not only lowers a person's risk of getting cancer and Alzheimer's disease, but may reduce the size of a hemorrhagic stroke. More...


Second-year medical student Jay McCracken is working with Dr. Krishnan Dhandapani, neuroscientist at the Medical College of Georgia (MCG; Augusta, GA, USA), using animal models to study curcumin's effect on intracerebral hemorrhages, bleeding in the brain caused by ruptured vessels.

Patients with this type of stroke are often treated for symptoms--such as headache and nausea--with medications, but not the stroke itself. Invasive surgery to remove the clot is usually required, but some patients may not be good candidates, according to Mr. McCracken. Approximately 17% of strokes are hemorrhagic, according to the American Stroke Association, and typically occur in people with high blood pressure.

"We found that curcumin significantly decreases the size of a blood clot, but we're not sure why it happens,” said the Mr. McCraken. He believes it may be because curcumin is a potent anti-inflammatory and antioxidant. For the study, he dissolved the yellow powder, which gives turmeric its color, in corn oil and injected it into the abdomen of an animal model of hemorrhagic stroke three times over three hours. He suspects less may work and is trying to establish the optimal dose and timing.

Timing is crucial for patients who often do not know they had a stroke and may not be seen by a physician for hours. "Usually, patients can experience other symptoms like seizures, vision, or cognitive problems, so they come to the [emergency room] fairly quickly under most circumstances,” remarked Dr. Dhandapani. "Many patients also arrive due to head trauma and are seen within an hour or so. However, treating these injuries, even after an hour, can be tricky.”

Patients most probably will need to get curcumin intravenously. The investigators think it may also help prevent strokes; they intend to pursue this line of research with the proposal of also making it available in a concentrated tablet form for those at-risk.

Related Links:
Medical College of Georgia



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.